AMY WARDEN: Open Payments
NPI 1740033562 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,385 in 32 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $814 · 2025 $2,385
Food & beverage: $2,385
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $406 |
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| E.R. Squibb & Sons, L.L.C. | 8 | $186 |
| Dexcom, Inc. | 1 | $163 |
| ABIOMED | 2 | $154 |
| Medtronic, Inc. | 1 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| Organon LLC | 1 | $138 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Madrigal Pharmaceuticals | 1 | $123 |
Products named: Ozempic, DEXCOM G7 GSS (161), Wegovy, INTERSTIM, Kerendia, VTAMA, STRENSIQ, WAINUA.
Industry payments across LA — which companies pay providers there.
